$Northwest Biotherapeutics (NWBO.US)$ Long-Term Survival: Th...
$Northwest Biotherapeutics(NWBO.US$ Long-Term Survival: The “long tail” of the survival curve showed that more than double the patients survived longer than those treated with the standard of care, highlighting the potential for long-term benefits.
Safety Profile: DCVax-L exhibited a benign safety profile, with adverse events not meaningfully different from the standard of care. This is particularly important as it means the therapy can be administered with fewer concerns about severe side effects
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Just a trader who likes stocks, buying high and selling low. 🦧
5Followers
5Following
23Visitors
Follow